CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Lenalidomide

来那度胺 杂质对照品Lenalidomide Impurities

54 个杂质条目54 impurity entries

本页汇总 来那度胺 的 54 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 54 impurity reference standards of Lenalidomide. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 来那度胺(Lenalidomide)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and validation of stability-indicating UHPLC-UV-MS tandem methods for lenalidomide assay, related substances, and genotoxic impurity monitoring
    Journal of pharmaceutical and biomedical analysis · 2025 · Ağtaş Ç, Bellur Atici E  ·  PMID 39978177  ·  DOI
  2. 分析方法Analytical MethodsSimultaneous determination of thirteen related substances in lenalidomide API by a stability-indicating RP-HPLC method
    Journal of pharmaceutical and biomedical analysis · 2025 · Cao Z et al.  ·  PMID 40120296  ·  DOI
  3. 分析方法Analytical MethodsQuality by design based ecofriendly HPLC analytical method for simultaneous quantification of erastin and lenalidomide in mesoporous silica nanoparticles
    Scientific reports · 2025 · Gupta A et al.  ·  PMID 40087405  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisChemoselective Synthesis of Lenalidomide-Based PROTAC Library Using Alkylation Reaction
    Organic letters · 2019 · Qiu X et al.  ·  PMID 31066567  ·  DOI
  • 合成方法SynthesisSynthesis of hapten and preparation of specific polyclonal antibody with high affinity for lenalidomide, the potent drug for treatment of multiple myeloma
    Chemistry Central journal · 2012 · Darwish IA et al.  ·  PMID 23101764  ·  DOI

来那度胺 —— 原料药与杂质对照品Lenalidomide — drug substance & impurities

共 55 个条目(含原料药本体)55 items incl. the drug substance
Lenalidomide structure
原料药 APIAPI
来那度胺Lenalidomide
Lenalidomide
CAS No.191732-72-6
Chemical FormulaC13H13N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide-d5A structure
—
来那度胺-d5ALenalidomide-d5A
Lenalidomide-d5A
CAS No.1227162-34-6
Chemical FormulaC13H8D5N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 1 structure
1
来那度胺杂质1Lenalidomide Impurity 1
Lenalidomide Impurity 1
CAS No.827026-45-9
Chemical FormulaC13H11N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 2 structure
2
来那度胺杂质2Lenalidomide Impurity 2
Lenalidomide Impurity 2
CAS No.2197414-57-4
Chemical FormulaC13H15N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 3 structure
3
来那度胺杂质3Lenalidomide Impurity 3
Lenalidomide Impurity 3
CAS No.295357-66-3
Chemical FormulaC13H14N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 5 structure
5
来那度胺杂质5Lenalidomide Impurity 5
Lenalidomide Impurity 5
CAS No.2197420-75-8
Chemical FormulaC13H15N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 7 structure
7
来那度胺杂质7Lenalidomide Impurity 7
Lenalidomide Impurity 7
CAS No.18583-89-6
Chemical FormulaC9H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 8 Monomer structure
8
来那度胺杂质8 单体Lenalidomide Impurity 8 Monomer
Lenalidomide Impurity 8 Monomer
CAS No.2353-44-8
Chemical FormulaC5H8N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 8 structure
8
来那度胺杂质8Lenalidomide Impurity 8
Lenalidomide Impurity 8
CAS No.24666-56-6
Chemical FormulaC5H8N2O2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 10 structure
10
来那度胺杂质10Lenalidomide Impurity 10
Lenalidomide Impurity 10
CAS No.2197414-56-3
Chemical FormulaC14H13N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 11 structure
11
来那度胺杂质11Lenalidomide Impurity 11
Lenalidomide Impurity 11
CAS No.1628915-10-5
Chemical FormulaC9H9NO5
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 12 structure
12
来那度胺杂质12Lenalidomide Impurity 12
Lenalidomide Impurity 12
CAS No.109444-53-3
Chemical FormulaC8H14N4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 13 structure
13
来那度胺杂质13Lenalidomide Impurity 13
Lenalidomide Impurity 13
CAS No.764-28-3
Chemical FormulaC8H12N4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 14 structure
14
来那度胺杂质14Lenalidomide Impurity 14
Lenalidomide Impurity 14
CAS No.2197414-55-2
Chemical FormulaC13H16N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 15 structure
15
来那度胺杂质15Lenalidomide Impurity 15
Lenalidomide Impurity 15
CAS No.1240215-76-2
Chemical FormulaC14H17N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 16 structure
16
来那度胺杂质16Lenalidomide Impurity 16
Lenalidomide Impurity 16
CAS No.1198299-53-4
Chemical FormulaC14H17N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 17 structure
17
来那度胺杂质17Lenalidomide Impurity 17
Lenalidomide Impurity 17
CAS No.1198299-50-1
Chemical FormulaC15H18N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 18 structure
18
来那度胺杂质18Lenalidomide Impurity 18
Lenalidomide Impurity 18
CAS No.1421593-78-3
Chemical FormulaC13H13N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 19 structure
19
来那度胺杂质19Lenalidomide Impurity 19
Lenalidomide Impurity 19
CAS No.295357-72-1
Chemical FormulaC13H12N2O7
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 20 structure
20
来那度胺杂质20Lenalidomide Impurity 20
Lenalidomide Impurity 20
CAS No.295357-73-2
Chemical FormulaC13H13N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 21 structure
21
来那度胺杂质21Lenalidomide Impurity 21
Lenalidomide Impurity 21
CAS No.1198299-72-7
Chemical FormulaC13H13N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 22 structure
22
来那度胺杂质22Lenalidomide Impurity 22
Lenalidomide Impurity 22
CAS No.2717380-87-3
Chemical FormulaC13H13N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 26 structure
26
来那度胺杂质26Lenalidomide Impurity 26
Lenalidomide Impurity 26
CAS No.1421593-80-7
Chemical FormulaC15H15N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 32 structure
32
来那度胺杂质32Lenalidomide Impurity 32
Lenalidomide Impurity 32
CAS No.59382-59-1
Chemical FormulaC9H9NO4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 33 structure
33
来那度胺杂质33Lenalidomide Impurity 33
Lenalidomide Impurity 33
CAS No.98475-07-1
Chemical FormulaC9H8BrNO4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 36 structure
36
来那度胺杂质36Lenalidomide Impurity 36
Lenalidomide Impurity 36
CAS No.2759287-45-9
Chemical FormulaC15H19N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 39 structure
39
来那度胺杂质39Lenalidomide Impurity 39
Lenalidomide Impurity 39
CAS No.1218910-61-2
Chemical FormulaC9H8ClNO4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 40 structure
40
来那度胺杂质40Lenalidomide Impurity 40
Lenalidomide Impurity 40
CAS No.65399-18-0
Chemical FormulaC8H5NO4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 41 structure
41
来那度胺杂质41Lenalidomide Impurity 41
Lenalidomide Impurity 41
CAS No.1975-51-5
Chemical FormulaC8H7NO4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 42 structure
42
来那度胺杂质42Lenalidomide Impurity 42
Lenalidomide Impurity 42
CAS No.1975-50-4
Chemical FormulaC8H7NO4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 43(Lenalidomide R-Isomer) structure
43
来那度胺杂质43(来那度胺R异构体)Lenalidomide Impurity 43(Lenalidomide R-Isomer)
Lenalidomide Impurity 43(Lenalidomide R-Isomer)
CAS No.874946-00-6
Chemical FormulaC13H13N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 44 structure
44
来那度胺杂质44Lenalidomide Impurity 44
Lenalidomide Impurity 44
CAS No.48103-74-8
Chemical FormulaC5H7NO3
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 45 structure
45
来那度胺杂质45Lenalidomide Impurity 45
Lenalidomide Impurity 45
CAS No.2093388-69-1
Chemical FormulaC17H21N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 46 structure
46
来那度胺杂质46Lenalidomide Impurity 46
Lenalidomide Impurity 46
CAS No.2133816-23-4
Chemical FormulaC14H15N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 50 structure
50
来那度胺杂质50Lenalidomide Impurity 50
Lenalidomide Impurity 50
CAS No.874760-71-1
Chemical FormulaC13H13N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 51 structure
51
来那度胺杂质51Lenalidomide Impurity 51
Lenalidomide Impurity 51
CAS No.191732-70-4
Chemical FormulaC13H13N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 52 structure
52
来那度胺杂质52Lenalidomide Impurity 52
Lenalidomide Impurity 52
CAS No.191732-74-8
Chemical FormulaC13H13N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 54 structure
54
来那度胺杂质54Lenalidomide Impurity 54
Lenalidomide Impurity 54
CAS No.2965-22-2
Chemical FormulaC8H6FNO4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 56 structure
56
来那度胺杂质56Lenalidomide Impurity 56
Lenalidomide Impurity 56
CAS No.2089206-55-1
Chemical FormulaC14H17N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 57 structure
57
来那度胺杂质57Lenalidomide Impurity 57
Lenalidomide Impurity 57
CAS No.6810-78-2
Chemical FormulaC5H7NO3
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 58 structure
58
来那度胺杂质58Lenalidomide Impurity 58
Lenalidomide Impurity 58
CAS No.827026-44-8
Chemical FormulaC13H14N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 59 structure
59
来那度胺杂质59Lenalidomide Impurity 59
Lenalidomide Impurity 59
CAS No.1450-76-6
Chemical FormulaC8H7NO4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 60 structure
60
来那度胺杂质60Lenalidomide Impurity 60
Lenalidomide Impurity 60
CAS No.870997-57-2
Chemical FormulaC9H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 61 structure
61
来那度胺杂质61Lenalidomide Impurity 61
Lenalidomide Impurity 61
CAS No.2408629-32-1
Chemical FormulaC11H12FNO5
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 62 structure
62
来那度胺杂质62Lenalidomide Impurity 62
Lenalidomide Impurity 62
CAS No.649736-31-2
Chemical FormulaC9H8FNO4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 63 structure
63
来那度胺杂质63Lenalidomide Impurity 63
Lenalidomide Impurity 63
CAS No.288385-99-9
Chemical FormulaC10H10FNO4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 64 structure
64
来那度胺杂质64Lenalidomide Impurity 64
Lenalidomide Impurity 64
CAS No.121247-16-3
Chemical FormulaC9H7F2NO3
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 65 structure
65
来那度胺杂质65Lenalidomide Impurity 65
Lenalidomide Impurity 65
CAS No.1022112-32-8
Chemical FormulaC12H11F2NO5
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 66 structure
66
来那度胺杂质66Lenalidomide Impurity 66
Lenalidomide Impurity 66
CAS No.1630974-89-8
Chemical FormulaC9H7Br2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 67 structure
67
来那度胺杂质67Lenalidomide Impurity 67
Lenalidomide Impurity 67
CAS No.6869-07-4
Chemical FormulaC8H14N4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 68(Lenalidomide S-Isomer) structure
68
来那度胺杂质68(来那度胺S异构体)Lenalidomide Impurity 68(Lenalidomide S-Isomer)
Lenalidomide Impurity 68(Lenalidomide S-Isomer)
CAS No.202271-91-8
Chemical FormulaC13H13N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 69 structure
69
来那度胺杂质69Lenalidomide Impurity 69
Lenalidomide Impurity 69
CAS No.7356-11-8
Chemical FormulaC9H9NO4
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 71 structure
71
来那度胺杂质71Lenalidomide Impurity 71
Lenalidomide Impurity 71
CAS No.2385152-82-7
Chemical FormulaC8H7NO5
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 72 structure
72
来那度胺杂质72Lenalidomide Impurity 72
Lenalidomide Impurity 72
CAS No.1483977-81-6
Chemical FormulaC13H13N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Lenalidomide Impurity 73 structure
73
来那度胺杂质73Lenalidomide Impurity 73
Lenalidomide Impurity 73
CAS No.1063995-49-2
Chemical FormulaC13H11N3O5
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

来那度胺 —— 研究文献与合成路线Lenalidomide — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 来那度胺 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Lenalidomide. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development and validation of stability-indicating UHPLC-UV-MS tandem methods for lenalidomide assay, related substances, and genotoxic impurity monitoring
    Ağtaş Ç, Bellur Atici E · Journal of pharmaceutical and biomedical analysis · 2025 · 被引 3cited 3
  2. Simultaneous determination of thirteen related substances in lenalidomide API by a stability-indicating RP-HPLC method
    Cao Z, Huang M, Bi L, et al. · Journal of pharmaceutical and biomedical analysis · 2025
  3. Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
    Yamanaka S, Furihata H, Yanagihara Y, et al. · Nature communications · 2023 · 被引 64cited 64
  4. Cancer therapies based on targeted protein degradation - lessons learned with lenalidomide
    Jan M, Sperling AS, Ebert BL · Nature reviews. Clinical oncology · 2021 · 被引 122cited 122
  5. Discovery and biological evaluation of proteolysis targeting chimeras (PROTACs) as an EGFR degraders based on osimertinib and lenalidomide
    He K, Zhang Z, Wang W, et al. · Bioorganic & medicinal chemistry letters · 2020 · 被引 48cited 48
  6. Discovery of new Lenalidomide derivatives as potent and selective GSPT1 degraders
    Wei Y, Xu X, Jiang M, et al. · European journal of medicinal chemistry · 2023 · 被引 14cited 14

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE PREPARATION OF LENALIDOMIDE
    KAPOOR MUNISH, KUMAR SARIDI MADHAVA DILEEP, MURUGESAN BALAGURU, SATHYANARAYANA SWARGAM, et al. · 公开号 WO2011027326WO2011027326 · 2011
  2. Process for the preparation of lenalidomide
    KAPOOR MUNISH, KUMAR SARIDI MADHAVA DILEEP, MURUGESAN BALAGURU, SATHYANARAYANA SWARGAM, et al. · 公开号 AU2010290822AU2010290822 · 2012
  3. PROCESS FOR THE PREPARATION OF FORM B OF LENALIDOMIDE
    KUMAR SARIDI MADHAVA DILEEP, KAPOOR MUNISH, SATHYANARAYANA SWARGAM, THAPER RAJESH KUMAR, et al. · 公开号 WO2011061611WO2011061611 · 2011
  4. LENALIDOMIDE SOLVATES AND PROCESSES
    RANGINENI SRINIVASULU, DUGGIRALA NAGAKIRAN, MUDAPAKA VAMSI KRISHNA, KADABOINA RAJASEKHAR, et al. · 公开号 US2011237802US2011237802 · 2011
  5. A CRYSTALLINE FORM OF LENALIDOMIDE AND A PROCESS FOR ITS PREPARATION
    BHOSALE PRIYANKA, GORE VINAYAK, PEHERE ASHOK, SHUKLA VINAY · 公开号 WO2010061209WO2010061209 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

来那度胺 杂质谱研究要点Lenalidomide — impurity profiling notes

下面这些是拿到 来那度胺 的 55 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 55 impurity entries for Lenalidomide, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances